JP Patent

JP7036782B2 — ミトコンドリアｄｎａ枯渇症候群を含む不均衡なヌクレオチドプールによって引き起こされる疾患のためのデオキシヌクレオシド療法

Assigned to Columbia University in the City of New York · Expires 2022-03-15 · 4y expired

What this patent protects

Patent listed against Kygevvi.

Drugs covered by this patent

Patent Metadata

Patent number
JP7036782B2
Jurisdiction
JP
Classification
—
Expires
2022-03-15
Drug substance claim
No
Drug product claim
No
Assignee
Columbia University in the City of New York
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.